Symantec 2008 Annual Report Download - page 179

The assumed options retained all applicable terms and vesting periods, except for certain options that were accelerated
according to a change in control provision and will generally vest within a twelve month period from the date of acquisition
and certain other options that vested in full as of the acquisition date. In general, the assumed options typically vest over a
period of four years from the original date of grant of the option and have a maximum term of ten years.
Assumed Altiris stock options and awards
In connection with our acquisition of Altiris, we assumed all of the outstanding options to purchase Altiris common
stock. Each option assumed was converted into an option to purchase Symantec common stock after applying the
exchange ratio of 1.9075 shares of Symantec common stock for each share of Altiris common stock. In total, we assumed
and converted Altiris options into options to purchase approximately 3 million shares of Symantec common stock. In
addition, we assumed and converted all outstanding Altiris RSUs into approximately 320,000 Symantec RSUs, based on
the same exchange ratio. Furthermore, we assumed all outstanding Altiris Restricted Stock Awards (“RSAs”) which
were converted into the right to receive cash in the amount of $33.00 per share upon vesting. The total value of the
assumed RSAs on the date of acquisition was approximately $9 million, assuming no RSAs are forfeited prior to vesting.
As of March 28, 2008, total unrecognized compensation cost adjusted for estimated forfeitures, related to the Altiris
unvested stock options, RSUs and RSAs, was $1 million, $1 million, and $1 million, respectively.
The assumed options, RSUs, and RSAs retained all applicable terms and vesting periods, except for certain
options, RSAs and RSUs that were accelerated according to the executive vesting plan and will generally vest over a
four to twelve month period from the date of acquisition and certain other options that vested in full as of the
acquisition date. In general, the assumed options typically vest over a period of three to four years from the original
date of grant and have a maximum term of ten years. The assumed RSUs and RSAs typically vest over a period of
two to three years from the original date of grant.
Assumed Veritas stock options
In connection with our acquisition of Veritas, we assumed each outstanding option to purchase Veritas
common stock with an exercise price equal to or less than $49.00 as well as each additional option required to be
assumed by applicable law. Each option assumed was converted into an option to purchase Symantec common stock
after applying the exchange ratio of 1.1242 shares of Symantec common stock for each share of Veritas common
stock. In total, we assumed and converted Veritas options into options to purchase 66 million shares of Symantec
common stock. In addition, we assumed and converted all outstanding Veritas RSUs into approximately 425,000
Symantec RSUs based on the same exchange ratio.
The assumed options and RSUs retained all applicable terms and vesting periods. In general, the assumed
options vest over a four-year period from the original date of grant. Options granted prior to May 2004 generally
have a maximum term of 10 years and options granted thereafter generally have a maximum term of seven years.
The assumed RSUs generally vest over a three or four year period from the original date of grant.
Other stock option plans
Options remain outstanding under several other stock option plans, including the 2001 Non-Qualified Equity
Incentive Plan, the 1999 Acquisition Plan, the 1996 Plan, and various plans assumed in connection with
acquisitions. No further options may be granted under any of these plans.
Acceleration of stock option vesting
On March 30, 2006, we accelerated the vesting of certain stock options with exercise prices equal to or greater
than $27.00 per share that were outstanding on that date. We did not accelerate the vesting of any stock options held
by our executive officers or directors. The vesting of options to purchase approximately 7 million shares of common
stock, or approximately 14% of our outstanding unvested options, was accelerated. The weighted-average exercise
price of the stock options for which vesting was accelerated was $28.73. We accelerated the vesting of the options to
97
SYMANTEC CORPORATION
Notes to Consolidated Financial Statements — (Continued)